Swedbank’s Strategic Bet on Varonis Amidst Operational Headwinds
27.12.2025 - 19:31:05Varonis US9222801022
The investment case for cybersecurity firm Varonis presents a stark contrast: significant operational challenges are being weighed against a major vote of confidence from a prominent institutional investor. Swedbank AB has aggressively increased its stake, a move that stands in sharp relief to the company's declining license revenue and persistent lack of profitability. This divergence raises a critical question for the market: can a single institution's backing restore faith while legal uncertainties and weak fundamentals persist?
Recent regulatory filings have highlighted a decisive move by Swedbank. During the third quarter of 2025, the bank expanded its position in Varonis by a substantial 363.1%. This purchase brings its total holdings to 328,309 shares, representing a market value of approximately $18.87 million. Such a pronounced accumulation during a period of share price weakness is often interpreted as a strategic, long-term commitment by a sophisticated market participant.
The stock recently closed at $33.41, a level that sits nearly 39% below its 52-week high of $54.66. This discount appears to have created an entry point for the bank.
Persistent Fundamental Weakness
However, this bullish institutional activity confronts a difficult operational reality. The company's Q3 2025 results revealed several concerning trends:
* Total revenue reached $161.6 million, falling short of analyst projections.
* Crucially, license and subscription revenues plummeted by 63.9% year-over-year.
* The net margin remained deep in negative territory at -18.82%.
* Management's guidance for Q4 2025 projects earnings per share (EPS) in a narrow range of just $0.02 to $0.04.
These figures explain the severe sell-off witnessed in late October and continue to cast a shadow over the equity. A sustainable recovery is unlikely until the company can stabilize its license sales and return to profitability.
Should investors sell immediately? Or is it worth buying Varonis?
Valuation Potential Versus Legal Overhang
From a valuation perspective, the narrative shifts. The average price target among covering analysts sits at $59.79. Independent discounted cash flow (DCF) models suggest a fair value near $58 per share. Compared to the current closing price of $33.41, this implies a theoretical upside potential of roughly 79%, or indicates the stock is undervalued by about 42% relative to its DCF-derived value.
Offsetting this potential is a legal investigation that adds a layer of risk. The law firm Kessler Topaz Meltzer & Check is examining potential securities law violations, alleging Varonis may have previously presented an overly optimistic picture of its recurring revenue stability, known as Annual Recurring Revenue (ARR). Such proceedings can introduce prolonged uncertainty and potential financial liabilities.
Key Data Summary:
* Swedbank Stake: Increased by 363.1% in Q3 2025 to 328,309 shares (~$18.87M value).
* Q3 2025 Revenue: $161.6M; License revenue down 63.9% YoY.
* Price Targets: Average analyst target: $59.79; DCF fair value: ~$58.
In the near term, the investment outlook hinges on two pivotal factors: the trajectory of license revenues in upcoming quarters and the resolution of the ongoing legal probe. Should the base of recurring revenues recover and major legal costs be avoided, valuation models confirm substantial upside potential. Conversely, if operational struggles continue or legal risks escalate, share price pressure is likely to remain.
Ad
Varonis Stock: Buy or Sell?! New Varonis Analysis from December 27 delivers the answer:
The latest Varonis figures speak for themselves: Urgent action needed for Varonis investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 27.
Varonis: Buy or sell? Read more here...


